Clinical Research
There are a number of clinical studies being conducted to investigate the safety and efficacy of a new treatment, a melatonin agonist, which resets the internal clock in people with circadian rhythm sleep disorders, including Non-24. A year-long (2011-2012) study at Harvard and at 26 other sites in the U.S. and Germany, is testing the use of tasimelteon in blind subjects with non-24-hour sleep-wake disorder.
Read more about this topic: Non-24-hour Sleep-wake Disorder
Famous quotes containing the word research:
“Our science has become terrible, our research dangerous, our findings deadly. We physicists have to make peace with reality. Reality is not as strong as we are. We will ruin reality.”
—Friedrich Dürrenmatt (1921–1990)